Although microdosing may go against the grain of the old time stoner philosophy, doctors say that finding the “minimum effective dose” is the key to medical treatment.

There are those cannabis connoisseurs who enjoy getting super stoned at the end of a long day at the office, while others are now embracing an emerging trend called microdosing, a procedure that allows the user to moderate their mind by taking small doses throughout the day.

On one hand, legal marijuana could prove to be one of the fastest-growing industries on the planet over the next decade. If investment bank Stifel's forecast of $200 billion in annual worldwide sales in 10 years proves accurate, we could be looking at a compound annual growth rate for cannabis of around 34%.

North America’s legal cannabis industry could be worth more than $47.3 (€43.23~) billion annually by 2024.

The North American Cannabis Report finds that despite Canada becoming the first G7 country to legalise adult-use cannabis, US cannabis market growth will greatly exceed its North American neighbour. Currently the most profitable industry in the world, the US, is expected to enjoy triple-digit growth by 2024, despite not having legalised cannabis on a federal scale.

When it comes to cannabis, the proof is in the peeing.

Canada’s national statistics agency has been collecting and testing municipal wastewater samples from five cities for traces of cannabis to gauge actual usage of the now legal drug. The results are surprising: In some cases they contradict other Statistics Canada data on pot use, while shedding light on the potential size of the black market.

Although microdosing may go against the grain of the old time stoner philosophy, doctors say that finding the “minimum effective dose” is the key to medical treatment.

There are those cannabis connoisseurs who enjoy getting super stoned at the end of a long day at the office, while others are now embracing an emerging trend called microdosing, a procedure that allows the user to moderate their mind by taking small doses throughout the day.

Less than two weeks after a Canadian woman was barred from entering the United States after she was found with cannabidiol (CBD) oil at the border, her lawyer says her lifetime ban from entering the states has been reversed in what he is calling a "best-case scenario."

The 21-year-old, who has asked not to be identified by CBC News, was crossing the border between B.C. and Washington state last month when CBD oil was found in her backpack.

CBD is a non-psychoactive product of the cannabis plant, and is used by the woman to treat the painful side-effects of scoliosis.

August was a dismal month for most marijuana stocks. More than half a dozen pot stocks with market caps greater than $200 million plunged 20% or more during the last month. Several others fell by double-digit percentages.

But there were a few exceptions to the August carnage. Three marijuana stocks performed really well last month: 22nd Century Group (NYSEMKT:XXII), Aphria (NYSE:APHA), and The Green Organic Dutchman (OTC:TGODF). Here's what drove these pot stocks higher and whether or not they're good picks to buy now.

All is not well in vapeland. Over the weekend, the Center for Disease Control (CDC) released a health alert with the headline: "Severe Pulmonary Disease Associated with Using E-Cigarette Products."